Evidence map›Paper›PMID 40499975›Full record

ArticleRMD open2025

Age at diagnosis as a prognostic factor in selected categories of juvenile idiopathic arthritis.

Anna-Kaisa Tuomi, Katariina Rebane, Ellen Arnstad, Lillemor Berntson, Anders Fasth, Mia Glerup, Troels Herlin, Hannu Kautiainen, Ellen Berit Nordal, Suvi Peltoniemi and 4 more

Abstract read
In one paragraph

Article in RMD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anna-Kaisa TuomiNew Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital, Helsinki, Uusimaa, Finland tuomi.annakaisa@gmail.com.ORCID 0000-0002-3244-2781
Katariina RebaneNew Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital, Helsinki, Uusimaa, Finland.
Ellen ArnstadDepartment of Pediatrics, Nord-Trøndelag Hospital Trust, Levanger, Norway.
Lillemor BerntsonDepartment of Women's and Children's Health, Uppsala Universitet, Uppsala, Sweden.
Anders FasthDepartment of Pediatrics, University of Gothenburg, Gothenburg, Sweden.
Mia GlerupDepartment of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-9128-9908
Troels HerlinDepartment of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
Hannu KautiainenPrimary Health Care Unit Kuopio, Kuopio University Hospital, Kuopio, Finland.
Ellen Berit NordalDepartment of Pediatrics and Pediatric Research Group, University Hospital of North Norway, Tromsø, Troms, Norway.
Suvi PeltoniemiUniversity of Helsinki, Helsinki, Uusimaa, Finland.
Marite RyggDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Trøndelag, Norway.
Veronika RypdalDepartment of Pediatrics and Pediatric Research Group, University Hospital of North Norway, Tromsø, Troms, Norway.ORCID 0000-0003-3476-305X
Marek ZakDepartment of Pediatrics, Copenhagen University Hospital, Copenhagen, Denmark.
Kristiina AaltoNew Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital, Helsinki, Uusimaa, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe age at the onset of juvenile idiopathic arthritis (JIA) can influence the trajectory of the disease. We aimed to clarify how age at the visit 6 months after the onset as a continuous variable affects long-term remission of JIA.

methodsThis study investigated 358 patients from the Nordic JIA cohort study. Age at diagnosis was analysed continuously. Three age groups were studied: under 3 years, 3-5 years and over 6 years of age. JIA was categorised as oligoarthritis, seronegative polyarthritis and others (enthesitis-related, psoriatic and undifferentiated arthritis). Clinical data, collected at 6 months after the onset of symptoms, included information about disease activity, uveitis, laboratory test values and medication. The outcomes assessed 17.5 years after diagnosis included remission, health-related quality of life (HRQoL), and functional ability.

resultsThe majority of patients with oligoarthritis and polyarthritis were diagnosed before age six, compared with 29% in the group of others. In the oligoarthritis group, predictors of remission included age at diagnosis, male gender, the Juvenile Arthritis Disease Activity Score-71 (JADAS71) and the absence of uveitis. In seronegative polyarthritis, predictors of remission were age at diagnosis and JADAS71 score. In the oligoarthritis group, remission rates were highest in both genders when diagnosed <3 years of age. In the seronegative polyarthritis group, this was not true for female patients. Age at diagnosis had no significant effect on HRQoL or functional ability.

conclusionsAge at diagnosis in the oligoarthritis was inversely and in the seronegative polyarthritis positively associated with long-term remission in JIA, primarily in females.

Indexed as

Arthritis, JuvenileAdolescentAge FactorsAge of OnsetChildChild, PreschoolFemaleHumansInfantMalePrognosisQuality of LifeRemission InductionSeverity of Illness IndexArthritis, JuvenileHealth-Related Quality Of LifeTreatment

Identifiers

PMID40499975
PMCPMC12161311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.